AbCellera Biologics Inc.

Rachunek Zysków i Strat


Finanse
Rachunek zysków i strat
Bilans
Przepływy pieniężne
Prognozy
Statystyki
Dywidendy
Rekomendacje
Modele wyceny
Wskaźniki
Analiza techniczna
index 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24
Rok finansowy 2019 2019 2019 2019 2020 2020 2020 2020 2021 2021 2021 2021 2022 2022 2022 2022 2023 2023 2023 2023 2024 2024 2024 2024 2025
Kwartał Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1
Data 2019-03-31 2019-06-30 2019-09-30 2019-12-31 2020-03-31 2020-06-30 2020-09-30 2020-12-31 2021-03-31 2021-06-30 2021-09-30 2021-12-31 2022-03-31 2022-06-30 2022-09-30 2022-12-31 2023-03-31 2023-06-30 2023-09-30 2023-12-31 2024-03-31 2024-06-30 2024-09-30 2024-12-31 2025-03-31
Przychód (mln) 2 2 3 3 5 11 9 208 203 28 6 139 317 46 101 22 12 10 7 9 10 7 7 5 4
Przychód Δ kw/kw 0.0% 0.0% 0.0% 0.0% 87.8% 352.9% 171.3% 6392.3% 4253.5% 146.2% -41.17% -32.98% 56.2% 66.1% 1740.6% -84.54% -96.15% -78.10% -93.49% -57.40% -18.36% -27.18% -1.39% -44.98% -57.45%
Marża brutto 18.9% 18.9% 19.4% -3.32% 11.6% 18.6% 19.9% 82.8% 90.1% 86.9% -216.81% 84.3% 85.9% 88.7% 85.2% 92.8% -331.82% 27.8% -12.27% 0.8% 32.0% -419.42% -488.52% 100.0% -903.45%
Koszty i Wydatki (mln) 3 3 3 5 6 4 10 49 42 30 29 52 86 53 61 58 74 57 59 72 65 101 100 78 109
EBIT (mln) -1 -1 -1 -2 -2 -1 -2 161 158 -7 -28 82 225 -7 38 -36 -62 -51 -55 -66 -55 -93 -94 -73 -105
EBIT Δ kw/kw 0.0% 0.0% 0.0% 0.0% 197.7% 19.8% 147.1% 8236.2% 7549.3% 723.5% 1489.1% -49.27% 42.3% -2.45% 234.3% -144.27% -127.34% 649.0% -245.46% 83.0% -10.74% 81.9% 70.6% 10.1% 91.6%
EBIT (%) -28.75% -28.75% -20.74% -61.70% -45.57% -7.61% -18.88% 77.3% 78.0% -25.44% -510.09% 58.5% 71.1% -14.94% 37.2% -167.57% -504.43% -511.03% -831.79% -719.61% -551.48% -1276.17% -1439.42% -1440.69% -2483.02%
Przychody fiansowe (mln) 0 0 0 0 0 0 0 0 0 0 0 0 1 1 6 15 10 11 11 11 10 10 10 9 0
Koszty finansowe (mln) 0 0 0 0 0 0 0 2 0 0 0 0 0 0 0 11 0 0 0 17 0 0 0 0 8
Amortyzacja (mln) 0 0 0 0 1 1 1 3 4 4 4 5 5 6 7 15 7 7 7 9 7 38 38 14 5
EBITDA (mln) -0 -0 -0 -1 -0 8 1 162 165 2 -21 95 236 -1 53 -16 -59 -40 -45 -59 -48 -57 -52 -55 -40
EBITDA(%) -12.82% -12.82% -9.43% -28.09% -9.58% 71.9% 5.4% 78.1% 81.5% 6.6% -354.21% 67.6% 74.3% -1.79% 46.0% -21.65% -446.03% -393.37% -676.66% -583.59% -483.50% -756.75% -797.25% -1095.27% -935.11%
NOPLAT (mln) -0 -0 0 -2 -2 7 -3 156 161 -2 -25 85 231 -7 47 -31 -48 -38 -39 -49 -43 -48 -63 -47 -53
Podatek (mln) 0 0 0 0 0 0 0 0 44 0 -4 25 62 -0 20 -2 -8 -7 -11 -1 -2 -11 -12 -13 -7
Zysk Netto (mln) -0 -0 0 -2 -2 7 -3 117 117 -2 -21 60 169 -7 27 -30 -40 -31 -29 -47 -41 -37 -51 -34 -46
Zysk netto Δ kw/kw 0.0% 0.0% 0.0% 0.0% 591.0% 2313.1% -7571.42% 7229.9% 5700.6% -134.66% 693.9% -48.76% 43.8% 192.1% 224.5% -149.86% -123.79% 349.9% -207.46% 57.7% 1.2% 21.0% 78.6% -27.44% 12.3%
Zysk netto (%) -12.22% -12.22% 1.0% -51.24% -44.94% 59.7% -28.77% 56.3% 57.8% -8.40% -388.16% 43.0% 53.2% -14.78% 26.3% -138.75% -328.99% -303.58% -433.55% -513.67% -407.98% -504.30% -785.42% -677.43% -1077.24%
EPS -0.002 -0.002 0.0002 -0.0076 -0.0097 0.0311 -0.0101 0.43 0.43 -0.0085 -0.08 0.21 0.54 -0.0238 0.0843 -0.1 -0.14 -0.11 -0.0988 -0.16 -0.14 -0.13 -0.17 -0.12 -0.15
EPS (rozwodnione) -0.002 -0.002 0.0002 -0.0069 -0.0088 0.0282 -0.0101 0.37 0.37 -0.0085 -0.0766 0.21 0.54 -0.0238 0.0843 -0.1 -0.14 -0.11 -0.0988 -0.16 -0.14 -0.13 -0.17 -0.12 -0.15
Ilośc akcji (mln) 151 151 159 215 215 215 266 270 270 272 267 279 311 285 316 287 288 289 289 290 293 294 295 294 298
Ważona ilośc akcji (mln) 151 151 152 238 238 238 266 320 320 272 279 279 311 285 316 287 288 289 289 290 293 294 295 294 298
Waluta USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD